Thu, September 7, 2023
Wed, September 6, 2023
Tue, September 5, 2023
Fri, September 1, 2023
Thu, August 31, 2023
Wed, August 30, 2023

Eric Joseph Maintained (AKRO) at Buy with Increased Target to $62 on, Sep 5th, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. with-increased-target-to-62-on-sep-5th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Eric Joseph of JP Morgan, Maintained "Akero Therapeutics, Inc." (AKRO) at Buy with Increased Target from $49 to $62 on, Sep 5th, 2023.

Eric has made no other calls on AKRO in the last 4 months.



There are 4 other peers that have a rating on AKRO. Out of the 4 peers that are also analyzing AKRO, 0 agree with Eric's Rating of Hold.



These are the ratings of the 4 analyists that currently disagree with Eric


  • Eliana Merle of "UBS" Initiated at Strong Buy and Held Target at $83 on, Monday, August 28th, 2023
  • Michael Ulz of "Morgan Stanley" Maintained at Buy with Increased Target to $70 on, Monday, June 12th, 2023
  • Ed Arce of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $64 on, Wednesday, June 7th, 2023
  • Edward Nash of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $59 on, Wednesday, May 17th, 2023

Publication Contributing Sources